A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in SwedenJ. Andersson, Jonas Bergh, Henrik Lindman et al.|Acta Oncologica|2002Cited by 22
Abstract P1-10-05: Omitting radiotherapy in women ≥ 65 years with early breast cancer and favorable histopathology after breast-conserving surgery, sentinel node biopsy and adjuvant endocrine therapy is safeKKA Villman, Göran Liljegren, Åsa Wickberg et al.|Cancer Research|2017Cited by 0